Nasdaq mrsn.

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Dec 4, 2023 · Mersana Therapeutics Inc (NASDAQ:MRSN) trade information. Sporting 15.15% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 12/01/23 when the MRSN stock price touched $1.90 or saw a rise of 10.38%. CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Adc Therapeutics SA (ADCT) shares have gone down -62.70% during the last six months, with a year-to-date growth rate less than the industry average at -19.60% against 15.30. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to shrink -50.00% this quarter and then jump 33.80% in the quarter after that.Mersana Therapeutics Inc stock price (MRSN). NASDAQ: MRSN. Buying or selling a stock that's not traded in your local currency?

Get the latest Mersana Therapeutics Inc (MRSN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Jan 25, 2023 · Follow. CAMBRIDGE, Mass., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline ...

CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

The average trading volume of MRSN on November 22, 2023 was 2.16M shares. MRSN) stock’s latest price update. Mersana Therapeutics Inc (NASDAQ: MRSN)’s stock price has gone decline by -1.25 in comparison to its previous close of 1.60, however, the company has experienced a 12.06% increase in its stock price over the last five trading days.Nov 24, 2023Jan 19, 2023 · That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 117.2% of MRSN's average daily trading volume over the past month, of 1.3 million shares. Mersana Therapeutics Inc. MRSN (U.S.: Nasdaq). AT CLOSE 4:00 PM EST 12/01/23. $1.90USD; 0.2515.15%. Volume3,085,773. AFTER HOURS 7:37 PM EST 12/01/23. $ ...Dec 1, 2023 · MRSN is trading within a range we consider fairly valued. Price $1.90. Dec 1, 2023. Fair Value ... Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

Precision BioSciences, Inc. Common Stock (DTIL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...Nov 22, 2023 · The average trading volume of MRSN on November 22, 2023 was 2.16M shares. MRSN) stock’s latest price update. Mersana Therapeutics Inc (NASDAQ: MRSN)’s stock price has gone decline by -1.25 in comparison to its previous close of 1.60, however, the company has experienced a 12.06% increase in its stock price over the last five trading days. CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript November 7, 2023 Mersana Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.31 ...

NASDAQ: Mersana Therapeutics Inc (MRSN) = 1.65 USD. Provided by Alpha Vantage. Mersana Therapeutics Inc stock (MRSN) in USD. 1 MRSN = 1.65 USD. 1 month. 6 months. 1 year. 5 years. Hold over 40 currencies to convert and send money at any time. Open an account. Mersana Therapeutics Inc stock performance at a glance. Check Mersana …Mersana Therapeutics, Inc. Common Stock (MRSN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Analyst Price Forecast Suggests 93.56% Upside. As of May 11, 2023, the average one-year price target for Mersana Therapeutics is 15.64. The forecasts range from a low of 12.12 to a high of $21.00 ...Mersana Therapeutics, Inc. Common Stock (MRSN) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. MRSN is trading within a range we consider fairly valued. Price $1.90. Dec 1, 2023. Fair Value ... Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Mar 13, 2023 · CAMBRIDGE, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody ...

CAMBRIDGE, Mass., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Find the latest Earnings Report Date for Mersana Therapeutics, Inc. Common Stock (MRSN) at Nasdaq.com.Net loss for the second quarter of 2023 was $54.3 million, or $0.47 per share, compared to a net loss of $52.2 million, or $0.55 per share, for the same period in 2022. Mersana Therapeutics is a ...The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating. Price Target Upside/Downside. According to ...CAMBRIDGE, Mass., April 05, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Mersana Therapeutics Inc. MRSN (U.S.: Nasdaq). AT CLOSE 4:00 PM EST 12/01/23. $1.90USD; 0.2515.15%. Volume3,085,773. AFTER HOURS 7:37 PM EST 12/01/23. $ ...CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Find the latest Insider Activity data for Mersana Therapeutics, Inc. Common Stock (MRSN) at Nasdaq.com.

Oct 16, 2023 · Analyzing the MRSN fundamentals. Recent quarter sales for Mersana Therapeutics Inc [NASDAQ:MRSN] were 10.65 billion which represents 148.69% growth. In the same period, the company’s revenue per employee was $176,033, whereas its income per employee was -$1,352,397.

Press release · 11/07 06:13. You can practice and explore trading MRSN stock methods without spending real money on the virtual paper trading platform. Webull offers MRSN …

The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating. Price Target Upside/Downside. According to ...The latest price target for . Mersana Therapeutics (NASDAQ: MRSN) was reported by Citigroup on July 28, 2023.The analyst firm set a price target for $1.00 expecting MRSN to fall to within 12 ... Stock analysis for Mersana Therapeutics Inc (MRSN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Mersana Therapeutics will host a conference call and webcast today at 8:00 a.m. ET to discuss these data. To access the call, please dial 877-303-9226 (domestic) or 409-981-0870 (international ...Apr 3, 2023 · Mersana Therapeutics (NASDAQ:MRSN) is a "Strong Buy" in my view, for three main reasons: Firstly, Mitigated Pneumonitis Risks: Despite concerns regarding UpRi's safety, specifically lung ... Mersana Therapeutics Inc (NASDAQ:MRSN) has announced new preclinical data of XMT-2056.Data were presented at the AACR-NCI-EORTC Virtual International Conference. XMT-2056 is an Immunosynthen STING ...CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that. Mersana Therapeutics Announces FDA has …CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Real time Mersana Therapeutics (MRSN) stock price quote, stock graph, news & analysis.CAMBRIDGE, Mass., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...

CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...Nov 24, 2023 · Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have earned a consensus rating of “Reduce” from the seven research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 1 […] Dec 4, 2023 · MRSN Earnings Date and Information. Mersana Therapeutics last announced its earnings data on November 7th, 2023. The reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.31) by $0.04. The company had revenue of $7.70 million for the quarter, compared to analyst estimates of $9.30 million. Instagram:https://instagram. thorne healthtech stockbest stock trading toolshow to buy carnival cruise stock without a brokersigma lithium corporation Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2023 Earnings Call Transcript November 7, 2023 Mersana Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.31 ... spy options trading hoursadvance auto news Advertisement Mersana Therapeutics, Inc. (MRSN) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 +0.0600 (+3.77%) At close: 04:00PM … the equalizer 3 in spanish Jul 13, 2021 · Mersana Therapeutics, Inc. (NASDAQ: MRSN) was in 25 hedge funds' portfolios at the end of March. The all time high for this statistic is 30. Our calculations also showed that MRSN isn't among the ... September 30, 2022 December 31, 2021 Cash, cash equivalents and marketable securities $ 290,126 $ 177,947: Working capital (1): 211,243 141,375: Total assets